Two novel biomarkers related to endothelial damage that have been identified in atherosclerosis research are platelet-activating factor (PAF) and lipoprotein-associated phospholipase A2 (Lp-PLA2) [9]. The gene discussed is PLA2G7; the disease is atherosclerosis.